Literature DB >> 32377238

THE ASSOCIATION BETWEEN PRO AND ANTI-INFLAMMATORY MARKERS WITH THE COMPONENTS OF METABOLIC SYNDROME.

S Kir1, K Ekiz1, H Alacam2, R Turkel1, E Koroglu1, B L Altintop1.   

Abstract

OBJECTIVES: Metabolic syndrome (MetS) is a cluster of metabolic abnormalities that is linked with increased circulating markers of oxidative stress and low-grade inflammation. The link between inflammation and MetS is not yet fully understood. We aim to evaluate the relationship between the levels of pro and anti-inflammatory markers such as apolipoprotein A1 (Apo-A1), apolipoprotein B (Apo-B), interleukin (IL) 6, tumor necrosis factor alpha (TNF-α), fibrinogen and complement component 3 (C3) and adiponectin and MetS/MetS components.
METHODS: This study was a case-control study conducted in an outpatient internal medicine clinic of the Ondokuz Mayıs University Internal Medicine Department. A total of 108 subjects (59 female, 49 male) who were not under any dietary restrictions and older than 17 years were selected and divided into two groups (54 with MetS and 54 healthy controls).
RESULTS: Increased levels of IL-6, C3 and Apo-B/Apo-A1 ratios and decreased levels of Apo-A1 and TNF-α (except in patients with hypertriglyceridemia) were detected in the MetS group. Apo-A1 and TNF-α exhibited decreased levels, and IL-6, fibrinogen, C3 and Apo-B levels and Apo-B/Apo-A1 ratios increased as higher numbers of MetS criteria were met in the total study group.
CONCLUSIONS: We found that inflammatory marker levels were not affected by an increased number of MetS criteria met in the MetS group although these levels increased in the control group with higher numbers of MetS components. The presence of a high number of MetS components does not have an additive pro-inflammatory contribution for subjects already diagnosed with MetS. ©by Acta Endocrinologica Foundation.

Entities:  

Keywords:  Metabolic syndrome; abdominal obesity; hyperglycemia; hypertension; hypertriglyceridemia; inflammatory markers

Year:  2019        PMID: 32377238      PMCID: PMC7200101          DOI: 10.4183/aeb.2019.430

Source DB:  PubMed          Journal:  Acta Endocrinol (Buchar)        ISSN: 1841-0987            Impact factor:   0.877


  33 in total

Review 1.  Inflammation as a cardiovascular risk factor.

Authors:  James T Willerson; Paul M Ridker
Journal:  Circulation       Date:  2004-06-01       Impact factor: 29.690

2.  Humoral markers of inflammation and endothelial dysfunction in relation to adiposity and in vivo insulin action in Pima Indians.

Authors:  Christian Weyer; John S Yudkin; Coen D A Stehouwer; Casper G Schalkwijk; Richard E Pratley; P Antonio Tataranni
Journal:  Atherosclerosis       Date:  2002-03       Impact factor: 5.162

3.  Adiponectin as a biomarker of the metabolic syndrome.

Authors:  Miwa Ryo; Tadashi Nakamura; Shinji Kihara; Masahiro Kumada; Satomi Shibazaki; Mihoko Takahashi; Masaki Nagai; Yuji Matsuzawa; Tohru Funahashi
Journal:  Circ J       Date:  2004-11       Impact factor: 2.993

4.  Comparison of apolipoprotein-B/apolipoprotein-AI in subjects with versus without the metabolic syndrome.

Authors:  Justo Sierra-Johnson; Virend Kristen Somers; Fatima Helena Sert Kuniyoshi; Carolina Ana Garza; William Luther Isley; Apoor Suresh Gami; Francisco Lopez-Jimenez
Journal:  Am J Cardiol       Date:  2006-09-29       Impact factor: 2.778

Review 5.  Adiponectin and metabolic syndrome.

Authors:  Yuji Matsuzawa; Tohru Funahashi; Shinji Kihara; Iichiro Shimomura
Journal:  Arterioscler Thromb Vasc Biol       Date:  2003-10-09       Impact factor: 8.311

Review 6.  Minireview: The adipocyte--at the crossroads of energy homeostasis, inflammation, and atherosclerosis.

Authors:  Michael W Rajala; Philipp E Scherer
Journal:  Endocrinology       Date:  2003-09       Impact factor: 4.736

Review 7.  Adipose tissue, insulin action and vascular disease: inflammatory signals.

Authors:  J S Yudkin
Journal:  Int J Obes Relat Metab Disord       Date:  2003-12

8.  The metabolic syndrome and inflammation.

Authors:  Julie P Sutherland; Benjamin McKinley; Robert H Eckel
Journal:  Metab Syndr Relat Disord       Date:  2004-06       Impact factor: 1.894

9.  Comparison of serum concentrations of C-reactive protein, TNF-alpha, and interleukin 6 between elderly Korean women with normal and impaired glucose tolerance.

Authors:  K M Choi; J Lee; K W Lee; J A Seo; J H Oh; S G Kim; N H Kim; D S Choi; S H Baik
Journal:  Diabetes Res Clin Pract       Date:  2004-05       Impact factor: 5.602

10.  Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase.

Authors:  T Yamauchi; J Kamon; Y Minokoshi; Y Ito; H Waki; S Uchida; S Yamashita; M Noda; S Kita; K Ueki; K Eto; Y Akanuma; P Froguel; F Foufelle; P Ferre; D Carling; S Kimura; R Nagai; B B Kahn; T Kadowaki
Journal:  Nat Med       Date:  2002-10-07       Impact factor: 53.440

View more
  3 in total

1.  The Promising Role of Microbiome Therapy on Biomarkers of Inflammation and Oxidative Stress in Type 2 Diabetes: A Systematic and Narrative Review.

Authors:  Pradipta Paul; Ridhima Kaul; Basma Abdellatif; Maryam Arabi; Rohit Upadhyay; Reya Saliba; Majda Sebah; Ali Chaari
Journal:  Front Nutr       Date:  2022-05-25

2.  The influence of diet therapeutic intervention on the sarcopenic index of patients with metabolic syndrome.

Authors:  T C Ghitea; S Vlad; D Birle; D M Tit; L Lazar; C Nistor-Cseppento; T Behl; S Bungau
Journal:  Acta Endocrinol (Buchar)       Date:  2020 Oct-Dec       Impact factor: 0.877

Review 3.  The Association Between Cardiometabolic Risk Factors and Frailty in Older Adults: A Systematic Review.

Authors:  Shamatree Shakya; Rashmita Bajracharya; Leila Ledbetter; Michael P Cary
Journal:  Innov Aging       Date:  2022-05-25
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.